SEC Filing Analysis: GoodRx Holdings, Inc. (GDRX)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director received a routine, non-cash award of deferred stock units as part of a compensation plan.
• Market Impact: The transaction is negligible in size and has no direct market impact.

Company Information

Field	Value
Company	GoodRx Holdings, Inc.
Ticker Symbol	GDRX
CIK	0001809519
Industry	SERVICES-COMPUTER PROCESSING & DATA PREPARATION

Insider Information

Field	Value
Name	Wagner Scott
CIK	0001342655
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-31
Transaction Code	A (Award)
Security Type	Class A Common Stock (as Deferred Stock Units)
Shares Involved	3,065
Price Per Share	$0.00
Total Value	$0
Shares Owned After	185,269 (Directly)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	3,065
% of Shares Outstanding	0.003%
Post-Transaction Ownership	368,169 shares (Direct & Indirect) (0.37% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction has a value of $0 and is immaterial against the company's $1.20 billion market capitalization.
• Ownership Concentration: The grant slightly increases the director's total holdings to 0.37% of outstanding shares, which is not a significant concentration.
• Dilution Impact: The issuance of 3,065 shares represents a negligible 0.003% dilution to existing shareholders.
• Transaction Significance: This is a routine compensation grant with no market-moving significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This is a standard, pre-disclosed form of director compensation. It is not an open-market transaction and does not signal any change in the insider's sentiment.

Volume & Sentiment

• Expected Volume Impact: None. This is not a market transaction.
• Sentiment Indicator: Neutral. The filing is informational regarding compensation.

Additional Context

Transaction Notes

• Special Circumstances: The filing notes these are Deferred Stock Units (DSUs) that vest in late 2025 and settle upon future events like separation from service. This is part of the 'GoodRx Holdings, Inc. Deferred Compensation Plan for Directors'.